Molecular Partners to Regain Global Rights for MP0310 from Amgen
Details : MP0310 is a dual-targeted compound, targeting both FAP and 4-1BB, that has the potential to activate T-cells and other immune cells, specifically in the tumor microenvironment, aiming to avoid systemic side effects associated with 4-1BB activation.
Brand Name : MP0310
Molecule Type : Large molecule
Upfront Cash : Not Applicable
April 26, 2022
LOOKING FOR A SUPPLIER?
Reset All
